<https://rdf.molmedb.upol.cz/reference/ref4164> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane19>,
		<https://identifiers.org/molmedb/MM00482>,
		<https://identifiers.org/molmedb/MM00083>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acsmedchemlett.0c00375"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00305>;
	<http://purl.org/ontology/bibo/pmid> "33329762"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494328>;
	<http://purl.org/dc/terms/bibliographicCitation> "Rossi M, Petralla S, Protti M, Baiula M, Kobrlova T, Soukup O, Spampinato SM, Mercolini L, Monti B, Bolognesi ML.: α-Linolenic Acid-Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis. ACS Med Chem Lett, Volume 11 (12), 2020"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494319>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30> .
<https://rdf.molmedb.upol.cz/interaction/int1019123> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4164> .
<https://rdf.molmedb.upol.cz/interaction/int1018624> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4164> .
<https://rdf.molmedb.upol.cz/interaction/int1018615> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4164> .
<https://rdf.molmedb.upol.cz/interaction/int1019080> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4164> .
<https://rdf.molmedb.upol.cz/interaction/int1018727> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4164> .
